BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AFSSI Sciences de la Vie - ECPv5.14.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AFSSI Sciences de la Vie
X-ORIGINAL-URL:https://www.afssi.fr
X-WR-CALDESC:Events for AFSSI Sciences de la Vie
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180205
DTEND;VALUE=DATE:20180208
DTSTAMP:20260526T061715
CREATED:20180112T102955Z
LAST-MODIFIED:20180112T102955Z
UID:4144-1517788800-1518047999@www.afssi.fr
SUMMARY:Toulouse Onco Week (TOW)
DESCRIPTION:In February 2016 \, Toulouse was at the forefront of the fight against cancer by hosting the Toulouse Onco Week (TOW).\nThe event taking place in the frame of the World Cancer Day aimed at gathering leading international scientists and major private and public players\,actors of research and care . \nThis widely publicized\, event featured promising scientiﬁc breakthroughs and the strong involvement of the medico-scientiﬁc community. The fight must go on. \n  \n« By bringing together scientific\, clinical and economic expertise to accelerate research and discovery of personalised therapeutic applications\, the Oncopole epitomises Toulouse’s commitment to innovation in the life sciences. The organization of Toulouse Oncoweek 2018 will be the opportunity for the researchers\, clinicians\, and biotechs to have high-level scientific exchanges in a city which places the excellence and the innovation at the heart of its action. » – Mr Jean-Luc Moudenc\, Mayor of Toulouse ; President of Toulouse Metropole. \n  \nScientific programme \nFebruary 5\, 2018 (9h00-12h00 A.M.) Metastasis and microenvironment – Metabolism  \nMetastasis & microenvironment\nKlaus Pantel (University Medical Center Hamburg-Eppendorf) \nMetabolism\nPierre Sonveaux (Université Catholique de Louvain)\nMatthew G Vander Heiden (MIT)\nJean-Emmanuel Sarry (Cancer Research Center of Toulouse) \nFebruary 5\, 2018 (14h00-17h00 P.M.) Genetic instability and DNA damage response\nJan Hoeijmakers (Erasmus University of Rotterdam)\nSteve Jackson (University of Cambridge)\nJean-Marc Egly (IGBMC\, Strasbourg)\nMark O’Connor (Astra-Zeneca)\nGaëlle Legube (Center for Integrative Biology\, Toulouse) \nFebruary 6\, 2018 (9h00-12h00 A.M.) Epigenetics – Non coding genome and cancer \nWith the support of \nEpigenetics (including epidemiology)\nMaarten van Lohuizen (The Netherlands Cancer Institute) \nNon-coding genome & cancer\nRamiro Garzon (The Ohio State University)\nMaite Huarte (University of Navarra)\nFrançois Payre (Center for Integrative Biology\, Toulouse) \nFebruary 6\, 2018 (14h00-17h00 P.M.) Cancer Immunotherapy\, from bench to bed \nJolanda De Vries (Radboud University Nijmegen)\nNathalie Rufer (University of Lausanne)\nJean-Philippe Girard (Institute of Pharmacology and Structural Biology\, Toulouse) \nFebruary 7\, 2018 (9h00-12h00 A.M.) New therapeutic strategies\nCombined therapies\nJulien Mazières (IUCT-Rangueil Larrey\, Cancer Research Center of Toulouse) \nRadiotherapy – Proton therapy\nJim Metz (University of Pennsylvania)\nGillies McKenna (University of Oxford) \nFebruary 7\, 2018 (14h00-17h00 P.M.) Clinical research on Melanoma\nRichard Marais (Cancer Research UK Manchester Institute)\nCéleste Lebbé (Hôpital Saint-Louis\, APHP)\nNicolas Meyer (IUCT-Oncopole\, Cancer Research Center of Toulouse)
URL:https://www.afssi.fr/event/toulouse-onco-week-tow/
CATEGORIES:Evénement filière
ATTACH;FMTTYPE=image/jpeg:https://www.afssi.fr/wp-content/uploads/2018/01/event-TOW-2018.jpg
END:VEVENT
END:VCALENDAR